Neuroblastoma 1

Common Name(s)

Neuroblastoma 1

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Neuroblastoma 1" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Neuroblastoma 1" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Neuroblastoma 1" returned 205 free, full-text research articles on human participants. First 3 results:

Role of Nrf2, HO-1 and GSH in Neuroblastoma Cell Resistance to Bortezomib.
 

Author(s): A L Furfaro, S Piras, C Domenicotti, D Fenoglio, A De Luigi, M Salmona, L Moretta, U M Marinari, M A Pronzato, N Traverso, M Nitti

Journal:

 

The activation of Nrf2 has been demonstrated to play a crucial role in cancer cell resistance to different anticancer therapies. The inhibition of proteasome activity has been proposed as a chemosensitizing therapy but the activation of Nrf2 could reduce its efficacy. Using the highly ...

Last Updated: 30 Mar 2016

Go To URL
Evaluation of potential prognostic value of Bmi-1 gene product and selected markers of proliferation (Ki-67) and apoptosis (p53) in the neuroblastoma group of tumors.
 

Author(s): Katarzyna Taran, Anna Wysocka, Anna Sitkiewicz, Józef Kobos, Ewa Andrzejewska

Journal:

 

Cancer in children is a very important issue in pediatrics. The least satisfactory treatment outcome occurs among patients with clinically advanced neuroblastomas. Despite much research, the biology of this tumor still remains unclear, and new prognostic factors are sought. The Bmi-1 ...

Last Updated: 5 Mar 2016

Go To URL
Apoptosis and necroptosis induced by stenodactylin in neuroblastoma cells can be completely prevented through caspase inhibition plus catalase or necrostatin-1.
 

Author(s): Letizia Polito, Massimo Bortolotti, Manuela Pedrazzi, Daniele Mercatelli, Maria Giulia Battelli, Andrea Bolognesi

Journal: Phytomedicine. 2016 Jan;23(1):32-41.

 

Stenodactylin is a highly toxic plant lectin purified from the caudex of Adenia stenodactyla, with molecular structure, intracellular routing and enzyme activity similar to those of ricin, a well-known type 2 ribosome-inactivating protein. However, in contrast with ricin, stenodactylin ...

Last Updated: 23 Feb 2016

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Neuroblastoma 1" returned 0 free, full-text review articles on human participants.

 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in Genetics Home Reference.

There are currently no related results available in GeneReviews.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

A Cancer Research UK Trial of Anti-GD2 T-cells (1RG-CART)
 

Status: Recruiting

Condition Summary: Relapsed or Refractory Neuroblastoma

 

Last Updated: 10 May 2016

Go to URL

Last Updated: 11 Dec 2015

Go to URL
High Risk Neuroblastoma Study 1.7 of SIOP-Europe (SIOPEN)
 

Status: Recruiting

Condition Summary: Neuroblastoma

 

Last Updated: 26 Sep 2016

Go to URL